cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation

Journal of Cellular Biochemistry

Volumn 67, Issue 3, 1997, Pages 353-366

  D'Angelo, Gisela ^a,b   Lee, Hsinyu ^a   Weiner, Richard I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSERM   (France)

Author keywords

Endothelial cells; MAPK; PKA; Raf 1

Indexed keywords

8 BROMO CYCLIC AMP; BASIC FIBROBLAST GROWTH FACTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; FIBROBLAST GROWTH FACTOR; FORSKOLIN; MITOGEN ACTIVATED PROTEIN KINASE; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CAPILLARY ENDOTHELIUM; CATTLE; CELL PROLIFERATION; ENDOTHELIUM CELL; ENZYME INHIBITION; INHIBITION KINETICS; MITOGENESIS; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL;

1-METHYL-3-ISOBUTYLXANTHINE; 8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ADENYLATE CYCLASE; ANIMALS; BRAIN; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CAPILLARIES; CATTLE; CELL DIVISION; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FIBROBLAST GROWTH FACTOR 2; FORSKOLIN; ISOPROTERENOL; ISOQUINOLINES; LYMPHOKINES; PHOSPHODIESTERASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-RAF; SIGNAL TRANSDUCTION; SULFONAMIDES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030664140     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19971201)67:3<353::AID-JCB7>3.0.CO;2-V     Document Type: Article

References (53)

1. 2+ mobilization, by cyclic AMP and GMP in rabbit aortic smooth-muscle cells. Biochem J 288:527-532.
2. Bacic F, McCarron RM, Uematsu S, Spatz M (1992): Adrenergic receptors coupled to adenylate cyclase in human cerebromicrovascular endothelium. Metab Brain Dis 7:125-137.
3. Barbara JG, Takeda K (1995): Voltage-dependent currents and modulation of calcium channel expression in zona fasciculata cells from rat adrenal gland. J Physiol 488: 609-622.
4. Benschop RJ, Nijkamp FP, Ballieux RE, Heijnen CJ (1994): The effects of beta-adrenoceptor stimulation on adhesion of human natural killer cells to cultured endothelium. Br J Pharmacol 113:1311-1316.
5. Brooker G, Harper JF, Terasaki WL, Moylan RD (1979): Radioimmunoassay of cyclic AMP and cyclic GMP. Adv Cyclic Nucleotide Res 10:1-33.
6. Burgering BM, Pronk GJ, van Weeren PC, Chardin P, Bos JL (1993): cAMP antagonizes p21ras-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor. EMBO J 12: 4211-4220.
7. Chabre O, Cornillon F, Bottari SP, Chambaz EM, Vilgrain I (1995): Hormonal regulation of mitogen-activated protein kinase activity in bovine adrenocortical cells: Cross-talk between phosphoinositides, adenosine 3′,5′-monophosphate, and tyrosine kinase receptor pathways. Endocrinology 136:956-964.
8. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Toshioka T, Hidaka H (1990): Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 265:5267-5272.
9. Connolly DT, Olander JV, Heuvelman D, Nelson R, Monsell R, Siegel N, Haymore BL, Leimgruber R, Feder J (1989): Human vascular permeability factor. Isolation from U937 cells. J Biol Chem 264:20017-20024.
10. Cook SJ, McCormick F (1993): Inhibition by cAMP of Ras-dependent activation of Raf. Science 262:1069-1072.
11. D'Angelo G, Struman I, Martial J, Weiner RI (1995): Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin. Proc Natl Acad Sci U S A 92:6374-6378.
12. Dent P, Haser W, Haystead TA, Vincent LA, Roberts TM, Sturgill TW (1992): Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro. Science 257:1404-1407.
13. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT (1992): The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255: 989-991.
14. Esch F, Baird A, Ling N, Ueno N, Hill F, Denoroy L, Klepper R, Gospodarowicz D, Bohlen P, Guillemin R (1985): Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proc Natl Acad Sci U S A 82:6507-6511.
15. Ferrara N, Henzel WJ (1989): Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851-858.
16. Ferrara N, Clapp C, Weiner R (1991): The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells. Endocrinology 129:896-900.
17. Ferrara N, Houck K, Jakeman L, Leung DW (1992): Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13:18-32.
18. Folkman J (1985): Tumor angiogenesis. Adv Cancer Res 43:175-203.
19. Folkman J, Shing Y (1992): Angiogenesis. J Biol Chem 267:10931-10934.
20. Fujii M, Ide T, Wadhwa R, Tahara H, Kaul SC, Mitsui Y, Ogata T, Oishi M, Ayusawa D (1995): Inhibitors of cGMP-dependent protein kinase block senescence induced by inactivation of T antigen in SV40-transformed immortal human fibroblasts. Oncogene 11:627-634.
21. Galea P, Thibault G, Lacord M, Bardos P, Lebranchu Y (1993): IL-4, but not tumor necrosis factor-alpha, increases endothelial cell adhesiveness for lymphocytes by activating a cAMP-dependent pathway. J Immunol 151: 588-596.
22. Gospodarowicz D, Cheng J (1986): Heparin protects basic and acidic FGF from inactivation. J Cell Physiol 128:475-484.
23. Graves LM, Bornfeldt KE, Raines EW, Potts BC, Macdonald SG, Ross R, Krebs EG (1993): Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc Natl Acad Sci U S A 90:10300-10304.
24. Habener JF (1990): Cyclic AMP response element binding proteins: A cornucopia of transcription factors. Mol Endocrinol 4:1087-1094.
25. Hafner S, Adler HS, Mischak H, Janosch P, Heidecker G, Wolfman A, Pippig S, Lohse M, Ueffing M, Kolch W (1994): Mechanism of inhibition of Raf-1 by protein kinase A. Mol Cell Biol 14:6696-6703.
26. Hordijk PL, Verlaan I, Jalink K, van Corven EJ, Moolenaar WH (1994): cAMP abrogates the p21ras-mitogen-activated protein kinase pathway in fibroblasts. J Biol Chem 269:3534-3538.
27. Howe LR, Leevers SJ, Gomez N, Nakielny S, Cohen P, Marshall CJ (1992): Activation of the MAP kinase pathway by the protein kinase raf. Cell 71:335-342.
28. Ida R, Lee A, Huang J, Brandi ML, Yamaguchi DT (1994): Prostaglandin-stimulated second messenger signaling in bone-derived endothelial cells is dependent on confluency in culture. J Cell Physiol 160:585-595.
29. Kaur G, Viallet J, Lorda J, Blair O, Gazdar AF, Minna JD, Sausville EA (1992): Growth inhibition by cholera toxin of human lung carcinoma cell lines: Correlation with GM1 ganglioside expression. Cancer Res 52:3340-3346.
30. Klagsbrun M, D'Amore PA (1991): Regulators of angiogenesis. Annu Rev Physiol 53:217-239.
31. Kyriakis JM, App H, Zhang XF, Banerjee P, Brautigan DL, Rapp UR, Avruch J (1992): Raf-1 activates MAP kinase-kinase. Nature 358:417-421.
32. Lange-Carter CA, Pleiman CM, Gardner AM, Blumer KJ, Johnson GL (1993): A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science 260:315-319.
33. Lee PL, Johnson DE, Cousens LS, Fried VA, Williams LT (1989): Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. Science 245: 57-60.
34. Leibovich SJ, Polverini PJ (1984): Protamine sulfate inhibition of serum-induced mitogenic responses: Differential effects on normal and neoplastic cells. J Natl Cancer Inst 73:1337-1347.
35. Leitman DC, Fiscus RR, Murad F (1986): Forskolin, phosphodiesterase inhibitors, and cyclic AMP analogs inhibit proliferation of cultured bovine aortic endothelial cells. J Cell Physiol 127:237-243.
36. Loesberg C, van Wijk R, Zandbergen J, van Aken WG, van Mourik JA, de Groot PG (1985): Cell cycle-dependent inhibition of human vascular smooth muscle cell proliferation by prostaglandin E1. Exp Cell Res 160:117-125.
37. Macdonald SG, Crews CM, Wu L, Driller J, Clark R, Erikson RL, McCormick F (1993): Reconstitution of the Raf-1-MEK-ERK signal transduction pathway in vitro. Mol Cell Biol 13:6615-6620 (published erratum appears in Mol Cell Biol (1994) 14:2223-2224).
38. Maione TE, Gray GS, Petro J, Hunt AJ, Donner AL, Bauer SI, Carson HF, Sharpe RJ (1990) Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247:77-79.
39. Manolopoulos VG, Samet MM, Lelkes PI (1995): Regulation of the adenylyl cyclase signaling system in various types of cultured endothelial cells. J Cell Biochem 57:590-598.
40. Nantel F, Bouvier M, Strosberg D, Marullo S (1995): Functional effects of long-term activation on human β2- and β1-adrenoceptor signalling. Br J Pharmacol 114:1045-1051.
41. Nilsson J, Olsson AG (1984): Prostaglandin E1 inhibits DNA synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor. Atherosclerosis 53:77-82.
42. Nishizuka Y (1986): Studies and perspectives of protein kinase C. Science 233:305-312.
43. Pastan IH, Johnson GS, Anderson WB (1975): Role of cyclic nucleotides in growth control. Annu Rev Biochem 44:491-522.
44. Post SR, Aguila-Buhain O, Insel PA (1996): A key role for protein kinase A in homologous desensitization of the beta 2-adrenergic receptor pathway in S49 lymphoma cells. J Biol Chem 271:895-900.
45. Ross EM, Maguire ME, Sturgill TW, Biltonen RL, Gilman AG (1977): Relationship between the beta-adrenergic receptor and adenylate cyclase. J Biol Chem 252:5761-5775.
46. Salomon Y, Londos C, Rodbell M (1974): A highly sensitive adenylate cyclase assay. Anal Biochem 58:541-548.
47. Sevetson BR, Kong X, Lawrence J Jr (1993): Increasing cAMP attenuates activation of mitogen-activated protein kinase. Proc Natl Acad Sci U S A 90:10305-10309.
48. Thomas KA (1987): Fibroblast growth factors. FASEB J 1:434-440.
49. Tool AT, Verhoeven AJ (1995): Inhibition of the production of platelet activating factor and of leukotriene B4 in activated neutrophils by nimesulide due to an elevation of intracellular cyclic adenosine monophosphate. Arzneimittelforschung 45:1110-1114.
50. Ullrich A, Schlessinger J (1990): Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212.
51. van Corven EJ, Hordijk PL, Medema RH, Bos JL, Moolenaar WH (1993): Pertussis toxin-sensitive activation of p21ras by G protein-coupled receptor agonists in fibroblasts. Proc Natl Acad Sci U S A 90:1257-1261.
52. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ, Sturgill TW (1993): Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 262:1065-1069.
53. Zhou Q, Hulea S, Kummerow FA (1995): Effects of adrenochrome and epinephrine on human arterial endothelial cells in vitro. Res Commun Mol Pathol Pharmacol 89:111-126.